Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint

Wang, Wan; Guo, Baoliang; Cui, Chunguo; Sun, Tong; Liu, Shengnan

doi:10.7150/jca.50501



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(8):2190-2198. doi:10.7150/jca.50501 This issue Cite

Review

Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint

Wan Wang^1✉, Baoliang Guo², Chunguo Cui¹, Tong Sun¹, Shengnan Liu¹

1. Department of Breast Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Blvd, Changchun 130033, China.
2. Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Street, Harbin 150001, China.

Citation:

Wang W, Guo B, Cui C, Sun T, Liu S. Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. J Cancer 2021; 12(8):2190-2198. doi:10.7150/jca.50501. https://www.jcancer.org/v12p2190.htm

Other styles

Abstract

Breast cancer is the most common malignant tumor in women globally. Currently, due to limited data, there are no international guidelines for addressing the management of a large group of patients during infectious disease pandemics. Coronavirus disease 2019 (COVID-19), declared as a pandemic by the World Health Organization (WHO), has rapidly spread globally. The COVID-19 pandemic changed our daily routines and forced us to rethink the management of breast cancer patients. Clinicians need to take into account multiple factors such as the timing and delivery of cancer care, epidemic prevention and control, and the allocation of medical resources. Determining ways to reasonably adjust the treatment strategy is a real challenge. In this review, we aim to discuss particular challenges associated with managing breast cancer patients during the COVID-19 pandemic, share experience from Chinese oncologists and surgeons and propose some practical approaches to the management of early-stage breast cancer patients from a surgical standpoint.

Keywords: Early-stage breast cancer, COVID-19, Neoadjuvant therapy, Surgical treatment, Adjuvant therapy, Treatment delay.

Citation styles

APA

Wang, W., Guo, B., Cui, C., Sun, T., Liu, S. (2021). Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. Journal of Cancer, 12(8), 2190-2198. https://doi.org/10.7150/jca.50501.

ACS

Wang, W.; Guo, B.; Cui, C.; Sun, T.; Liu, S. Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. J. Cancer 2021, 12 (8), 2190-2198. DOI: 10.7150/jca.50501.

NLM

CSE

Wang W, Guo B, Cui C, Sun T, Liu S. 2021. Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. J Cancer. 12(8):2190-2198.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.